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Abstract
Background: We describe an alternative method to determine mRNA half-life (t1/2) based on the
Real-Time RT-PCR procedure. This approach was evaluated by using the β -actin gene as a
reference molecule for measuring of mRNA stability.
Results: Human leukemia Nalm-6 and CCRF-CEM cells were treated with various concentrations
of Actinomycin D to block transcription and aliquots were removed periodically. Total RNA was
isolated and quantified using the RiboGreen® fluorescent dye with the VersaFluor Fluorometer
System. One µg of total RNA was reverse transcribed and used as template for the amplification
of a region of the β -actin gene (231 bp). To generate the standard curve, serial ten-fold dilutions
of the pBactin-231 vector containing the cDNA amplified fragment were employed, β -actin mRNAs
were quantified by Real-Time RT-PCR using the SYBR® Green I fluorogenic dye and data analyzed
using the iCycle iQ system software. Using this method, the β -actin mRNA exhibited a half-life of
6.6 h and 13.5 h in Nalm-6 and CCRF-CEM cells, respectively. The t1/2 value obtained for Nalm-6
is comparable to those estimated from Northern blot studies, using normal human leukocytes (5.5
h).
Conclusions: We have developed a rapid, sensitive, and reliable method based on Real-Time RT-
PCR for measuring mRNA half-life. Our results confirm that β -actin mRNA half-life can be affected
by the cellular growth rate.
Background
Determination of mRNA half-life is important to our un-
derstanding of gene expression and mechanisms involved
in the regulation of the level of transcripts in response to
environmental changes or developmental cues. In addi-
tion, the stability of mRNA may determine how rapidly
the synthesis of the encoded protein can be shut down af-
ter transcription ceases. mRNA half-life can be determined
by densitometric analysis of in situ hybridization histo-
chemistry [1] or by Northern blot analysis [2] of RNA
samples removed from cells treated with transcriptional
inhibitors such as actinomycin D (ActD) [3], α -amanitin
[4], or 5,6-dichloro-1-β -D-ribofuranosylbenzimidazole
(DRB) [5]. Although reliable, these multi-step methods
are laborious and time-consuming. The advent of new
technologies such as the Real-Time PCR allows rapid and
exact measurement of copy number of molecules present
in the sample [6]. Real-Time Reverse Transcriptase PCR
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(RT-PCR) allows precise and reproducible quantitative
determination of the number of mRNA transcripts synthe-
sized [7,8]. We have developed a rapid and reliable Real-
Time quantitative RT-PCR approach to determine mRNA
half-life based on the SYBR® Green I fluorogenic dye (Mo-
lecular Probes, Inc., Eugene, OR, USA) and relative to the
amount of total RNA per cell samples.
To evaluate that approach, the β -actin gene was used as a
reference molecule for mRNA stability. Actin proteins are
components of the microfilament which play a crucial
role in maintaining cell shape and motility. Expression of
β -actin has been shown to be relatively constant as cells
progress through the cell cycle [9] and has been used as a
standard for an unchanging protein and mRNA in studies
of gene regulation. In this study, we used the human
leukemia cell lines CCRF-CEM (T-cell lineage, Acute Lym-
phoblastic Leukemia (ALL)) and Nalm-6 (B-cell precur-
sor, ALL) that respond differently to antifolate drugs, such
as methotrexate (MTX). Nalm-6 cells were shown to be
more sensitive to MTX when compared to CCRF-CEM
[10].
Results and Discussion
The β -actin mRNA half-life was determined from CCRF-
CEM and Nalm-6 cell lines treated with 0.5 µM, 1 µM, and
5 µM ActD (Sigma-Genosys, Woodlands, TX, USA). Under
these conditions, Naml-6 cells were more sensitive than
CCRF-CEM cells as measured by viable cell counts. It has
been shown that ActD inhibits cell proliferation by form-
ing a stable complex with single-stranded DNA and block-
ing the movement of RNA polymerase that interferes with
DNA-dependent RNA synthesis [11]. Based on their re-
spective IC50 for ActD, β -actin mRNA half-life was evalu-
ated from Nalm-6 cells treated with 0.5 µM and 1 µM
ActD, and from CCRF-CEM cells treated with 1 µM and 5
µM ActD. Twenty-four h before treatment, the cells were
transferred to a tissue culture flask at a concentration of 6
×  105 cells/ml, and aliquots of 3 ×  106 cells were collected
every 2 or 4 h for a period of 8 to 24 h. Total RNA was iso-
lated and its concentration determined as described in
Materials and Methods. For each sample, the amount of β -
actin mRNA was quantified relative to 1 µg of total RNA
by Real-Time RT-PCR. First-strand cDNA was synthesized
using 1 µg of total RNA (DNase-treated) and a region of
the β -actin mRNA was amplified using primers BA67 and
BA68 [12]. Serial ten-fold dilutions (104 to 109 mole-
cules) of pBactin-231 were used as a reference molecule
for the standard curve calculation (Figure 2). All Real-
Time PCR quantitations were performed using the BIO-
RAD iCycler iQ system (BioRad, Hercules, CA, USA). A
representative example of RT-PCR amplification plots is
shown in Figure 1. A fluorescence threshold value (Ct)
was calculated for each samples. For each standard curve,
the correlation coefficients ranged from 0.988 to 0.995 in-
dicating a high degree of confidence for the measurement
of the copy number of molecules in the samples. As
shown in Figure 2, the number of β -actin mRNA mole-
cules ranged between 107 to 108 molecules/µl of cDNA
for most of the cDNA preparations. Melting curves con-
firmed the presence of a single amplification product.
Amounts of β -actin mRNA molecules were calculated for
each time-point and plotted as a function of time (Figure
3). In Nalm-6 cells, the β -actin mRNA exhibited a half-life
of 6.6 h. This result is comparable to the previously report-
ed published value of approximately 5.5 h [13] using the
traditional Northern blot procedure. A significant higher
half-life value of ~13.5 h was obtained with the CCRF-
CEM cells. It is interesting to observe a two-fold difference
for β -actin mRNA half-life between these two cell lines.
This difference cannot be explained by the concentrations
of the ActD used to block transcription because similar
half-life values were obtained with different ActD concen-
trations (see Figure 3). However, since the expression of
the β -actin gene is regulated as a function of the cell cycle
with transcription in the G1 phase and mRNA decay in G2
phase [14,15], it is possible that this difference in β -actin
mRNA half-life could be explained by their respective cel-
lular growth rate. Indeed, CCRF-CEM and Nalm-6 cells ex-
hibited different cellular growth rate with generation
times of 24 and 36 h, respectively. Taken together, this
suggests that cells growing at a slower rate such as Nalm-
6 would process the β -actin mRNA at a faster rate in order
to respond to its cytoskeleton requirement. Future experi-
ments will address this issue.
Conclusions
In summary, we described an alternative method using
Real-Time RT-PCR to determine the rate of mRNA degra-
dation by accurately measuring the number of mRNA
molecules relative to total RNA. Using this approach, we
obtained a values for the β -actin mRNA half-life in Nalm-
6 cells that are comparable to those estimated from North-
ern blot studies using normal human leukocytes [13].
Therefore, Real-Time RT-PCR is a reliable method for
measuring mRNA half-life. Because of its sensitivity, half-
life of mRNAs expressed at very low level can be deter-
mined in cases in which Northern blots may not be sensi-
tive enough. The length of the amplified fragment is
important to determine the mRNA half-life because in-
complete or degraded mRNA can interfere with the meas-
urement of the actual mRNA half-life. Ideally, full-length
cDNA molecules should be amplified to ensure integrity
and identity of the mRNA species. The use of the fluoro-
genic SYBR Green I dye limits the length of the amplified
product (cDNA recommended to be less than 200 bp).
However, the use of TaqMan® (Applied Biosystems, Foster
City, CA, USA), molecular beacons (Molecular Probes,
Inc., Eugene, OR, USA), or fluorescence resonance energy
transfer (FRET) probes (Roche Molecular Biochemicals,Cancer Cell International 2002, 2 http://www.cancerci.com/content/2/1/1
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Indianapolis, IN, USA) could overcome this limitation
and allow amplification of longer PCR products. In addi-
tion, since multiplex Real-Time RT-PCR can be achieved
in the same reaction tube using different fluorogenic dyes,
this method could be modified to simultaneously esti-
mate mRNA half-life of several genes. Thus, our approach




The human leukemia cell lines CCRF-CEM (T-cell, ALL)
and Nalm-6 (B-cell precursor, ALL) were obtained from
the American Type Culture Collection (ATCC, Rockville,
MD, USA) and DSMZ (Braunschweig, Germany), respec-
tively. Both cell lines were grown in RPMI 1640 (Sigma-
Genosys, Woodlands, TX, USA) supplemented with 10%
fetal bovine serum at 37°C under a 5% CO2 atmosphere.
Figure 1
Real-Time RT-PCR amplification plot of β -actin mRNA. Representative RT-PCR plot resulting from the amplification
of β -actin cDNA templates (1/20 volume) synthesized from 1 µg of total RNA (see Materials and Methods for details). For
each time point, the cDNA was generated and quantified from three independent experiments and run in triplicates. The calcu-
lated cycle threshold (Ct = 99) provides an arbitrary cut off point at which a Ct value is assigned for each sample.
Figure 2
Real-Time RT-PCR quantification of β -actin mRNA. Standard curve showing amplification efficiencies of ten-fold serial
dilutions of the pBactin-231 template. Real-Time PCR amplifications were performed using β -actin specific primers BA67 and
BA68. The calculated Ct values were plotted versus the log of the initial amount of pBactin-231 molecules (104 to 109) to gen-
erate the standard curve. Squares and circles represent β -actin standards and mRNA samples, respectively.Cancer Cell International 2002, 2 http://www.cancerci.com/content/2/1/1
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Culture medium was changed according to standard tis-
sue culture techniques to insure cellular integrity. Trypan
blue exclusion methodology was used to assess cell viabil-
ity.
RNA isolation and Real Time RT-PCR
Total RNA was isolated using the RNeasy kit (Qiagen, Inc.,
Valencia, CA, USA) and its concentration determined us-
ing the RiboGreen® fluorescent dye (Molecular Probes,
Inc., Eugene, OR, USA) with the VersaFluor Fluorometer
System (BioRad, Hercules, CA, USA). Quality and integri-
ty of total RNA was assessed on 1% formaldehyde-agarose
gels. First-strand cDNA was synthesized using 1 µg of total
RNA (DNase-treated) in a 20 µl reverse transcriptase reac-
tion mixture as described by Leclerc and Barredo [16]. A
region of the β -actin mRNA was amplified using primers
BA67 (5'-GCGGGAAATCGTGCGTGACATT) and BA68
(5'-GATGGAGTTGAA GGTAGTTTCGTG), as described by
Lenz et al. [12]. The cDNA amplified fragment (231 bp)
was cloned into the pCR2.1-TOPO vector (Invitrogen,
Carlsbad, CA, USA) to generate the plasmid pBactin-231
(4139 bp). Serial ten-fold dilutions (104 to 109 mole-
cules) of pBactin-231 were used as a reference molecule
for the standard curve calculation (Figure 2). All Real-
Time PCR reactions were performed in a 25 µl mixture
containing 1/20 volume of cDNA preparation (1 µl), 1X
Figure 3
Half-life of β -actin mRNA in Nalm-6 and CCRF-CEM cells. The CCRF-CEM cells were treated with 5 µM (squares) or
1 µM (circles) Act-D for various times to block mRNA synthesis. Similarly, the Nalm6 cells were treated with 1 µM (lozenges)
or 0.5 µM (triangles) Act-D. Total RNA, cDNA, and Real-Time PCR amplification were performed as described in the text.
The values represent the mean (±) the standard deviation (SD) of the β -actin RNA copy number per µg of total RNA from
three independent experiments. Triplicate determinations were averaged at each data-point. The inset shows the calculated
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SYBR Green buffer (PE Applied Biosystems, Foster City,
CA, USA), 4 mM MgCl2, 0.2 µM of each primers (BA67
and BA68), 0.2 mM dNTPs mix and 0.025 Unit of Ampli-
Taq Gold® thermostable DNA polymerase (Applied Bio-
systems, Foster City, CA, USA). Real-Time quantitations
were performed using the BIO-RAD iCycler iQ system
(BioRad, Hercules, CA, USA). The fluorescence threshold
value was calculated using the iCycle iQ system software.
Acknowledgements
The authors would like to thank Florence B. Leclerc and Sanja Altman-
Hamamdzic for helpful discussion, and the Medical University of South 
Carolina, Biotechnology Resource Laboratory, Charleston, SC, for their as-
sistance with DNA sequence analysis. This work was supported in part by 
research Grant NIH/NCI CA72734 (to J. C. B.) and the Jolly Foundation 
Award (to G. J. L. and J. C. B.) and by the Monica Kreber Golf Classic, Char-
leston, SC.
References
1. Wilkinson DG: In Situ Hybridization. A Practical Approach. Ox-
ford University Press, New York 1992
2. Sambrook J, Fritsch EF, Maniatis T: Molecular Cloning. A Laboratory
Manual  CSJ Laboratory Press, Cold Spring Harbor, New York 1989
3. Sobell HM: Actinomycin and DNA transcription.  Proc. Natl.
Acad. Sci. USA 1985, 82:5328-5331
4. de Mercoyrol L, Job C, Job D: Studies on the inhibition by alpha-
amanitin of single-step addition reactions and productive
RNA synthesis catalyzed by wheat-germ RNA polymerase II.
Biochem. J. 1989, 258:165-169
5. Egyhazi E: Initiation inhibition and re-initiation of the synthesis
of heterogeneous nuclear RNA in living cells. Nature 1976,
262:319-321
6. Higuchi R, Fockler C, Dollinger G, Watson R: Kinetic PCR: Real
time monitoring of DNA amplification reactions. Biotechnology
1993, 11:1026-1030
7. Gibson UEM, Heid CA, Williams PM: A novel method for real-
time quantitative RT-PCR. Genome Res. 1996, 6:995-1001
8. Heid C, Stevens J, Livak K, Williams PM: Real time quantitative
PCR, Genome Res. 1996, 6:986-994
9. Bravo R, Celis JE: A search for differential polypeptide synthe-
sis throughout the cell cycle of HeLa cells. J. Cell Biol. 1980,
84:795-802
10. Galpin AJ, Schuetz JD, Masson E, Yanishevski Y, Synold TW, Barredo
JC, Pui CH, Relling MV, Evans WE: Differences in Folylpolygluta-
mate Synthetase and dihydrofolate reductase expression in
human B-lineage versus T-lineage leukemic lymphoblasts:
mechanisms for lineage differences in methotrexate poly-
glutamylation and cytotoxicity. Mol. Pharmacol. 1997, 52:155-
163
11. Wadkins RM, Jares-Erijman EA, Klement R, Rudiger A, Jovin TM: Ac-
tinomycin D binding to single-stranded DNA: sequence spe-
cificity and hemi-intercalation model from fluorescence and
1H NMR spectroscopy. J. Mol. Biol. 1996, 262:53-68
12. Lenz HJ, Danenberg K, Schnieders B, Goeker E, Peters GJ, Garrow T,
Shane B, Bertino JR, Danenberg PV: Quantitative analysis of folyl-
polyglutamate synthetase gene expression in tumor tissues
by polymerase chain reaction: marked variation of expres-
sion among leukemia patients. Oncol. Res. 1994, 6:329-335
13. Villarete LH, Remick DG: Transcriptional and post-transcrip-
tional regulation of lnterleukin-8. Am. J. Pathol. 1996, 149:1685-
1693
14. DePonti-Zilli L, Seiler-Tuyns A, Paterson BM: A 40-base-pair se-
quence in the 3' end of the beta-actin gene regulates beta-ac-
tin mRNA transcription during myogenesis. Proc. Natl. Acad. Sci.
USA 1988, 85:1389-1393
15. Sympson CJ, Geoghegan TE: Actin gene expression in murine
erythroleukemia cells treated with cytochalasin D. Experimen-
tal Cell Research 1990, 189:28-32
16. Leclerc GJ, Barredo JC: Folylpoly-γ -glutamate synthetase gene
mRNA splice variants and protein expression in primary hu-
man leukemia cells, cell lines, and normal human tissues. Clin.
Cancer Res. 2001, 7:942-951
Publish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMedcentral will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Paul Nurse, Director-General, Imperial Cancer Research Fund
Publish with BMC and your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours - you keep the copyright
editorial@biomedcentral.com
Submit your manuscript here:
http://www.biomedcentral.com/manuscript/
BioMedcentral.com